-
1
-
-
0026418434
-
-
a) B. M. Trost, Science 1991, 254, 1471;
-
(1991)
Science
, vol.254
, pp. 1471
-
-
Trost, B.M.1
-
5
-
-
0030811719
-
-
a) A. Orita, Y. Yamashita, A. Toh, J. Otera, Angew. Chem. Int. Ed. Engl. 1997, 36, 779;
-
(1997)
Angew. Chem. Int. Ed. Engl
, vol.36
, pp. 779
-
-
Orita, A.1
Yamashita, Y.2
Toh, A.3
Otera, J.4
-
8
-
-
0033525447
-
-
d) A. Orita, A. Watanabe, H. Tsuchiya, J. Otera, Tetrahedron 1999, 55, 2889;
-
(1999)
Tetrahedron
, vol.55
, pp. 2889
-
-
Orita, A.1
Watanabe, A.2
Tsuchiya, H.3
Otera, J.4
-
9
-
-
0032918557
-
-
e) A. Orita, N. Yoshioka, P. Struwe, A. Braier, A. Beckmann, J. Otera, Chem. Eur. J. 1999, 5, 1355;
-
(1999)
Chem. Eur. J
, vol.5
, pp. 1355
-
-
Orita, A.1
Yoshioka, N.2
Struwe, P.3
Braier, A.4
Beckmann, A.5
Otera, J.6
-
10
-
-
0345977284
-
-
K. Kitaori, Y. Furukawa, H.; Yoshimoto, J. Otera, Adv. Synth. Catal. 2001, 343, 95.
-
f) K. Kitaori, Y. Furukawa, H.; Yoshimoto, J. Otera, Adv. Synth. Catal. 2001, 343, 95.
-
-
-
-
15
-
-
4544229509
-
-
A. Orita, J. Okano, Y. Tawa, L. Jiang, J. Otera, Angew. Chem. Int. Ed. 2004, 43, 3724.
-
(2004)
Angew. Chem. Int. Ed
, vol.43
, pp. 3724
-
-
Orita, A.1
Okano, J.2
Tawa, Y.3
Jiang, L.4
Otera, J.5
-
16
-
-
34948835433
-
-
Assigned to PathoGenesis Corp, World Patent WO97/01562
-
a) Assigned to PathoGenesis Corp, World Patent WO97/01562, 1997;
-
(1997)
-
-
-
17
-
-
0034702247
-
-
b) C. K. Stover, P. Warrener, D. R. VanDevanter, D. R. Sherman, T M. Arain, M. H. Langhorne, S. W. Anderson, J. A. Towell, Y. Yuan, D. N. McMurry, B. N. Kreiswirth, C. E. Barry, W. R. Baker, Nature 2000, 405, 962.
-
(2000)
Nature
, vol.405
, pp. 962
-
-
Stover, C.K.1
Warrener, P.2
VanDevanter, D.R.3
Sherman, D.R.4
Arain, T.M.5
Langhorne, M.H.6
Anderson, S.W.7
Towell, J.A.8
Yuan, Y.9
McMurry, D.N.10
Kreiswirth, B.N.11
Barry, C.E.12
Baker, W.R.13
-
18
-
-
34948890768
-
-
Homepage of the Global Alliance for TB Drug Development
-
Homepage of the Global Alliance for TB Drug Development, http://www.tballiance.org.
-
-
-
-
19
-
-
34948909411
-
-
Evaluation of 6b in CIN/IP-2 is difficult on account of its unsatisfactory purity.
-
Evaluation of 6b in CIN/IP-2 is difficult on account of its unsatisfactory purity.
-
-
-
-
20
-
-
57249105046
-
-
a) A. D. Curzons, D. J. C. Constable, D. N. Mortimer, V.L. Cunningham, Green Chem. 2001, 3, 1;
-
(2001)
Green Chem
, vol.3
, pp. 1
-
-
Curzons, A.D.1
Constable, D.J.C.2
Mortimer, D.N.3
Cunningham, V.L.4
-
22
-
-
34948908148
-
-
See Supporting Information for calculations of RME and the amount of solvents
-
See Supporting Information for calculations of RME and the amount of solvents.
-
-
-
-
24
-
-
0000178030
-
-
H. Kotsuki, Y. Ushio, I. Kadota, M. Ochi, J. Org. Chem. 1989, 54, 5153.
-
(1989)
J. Org. Chem
, vol.54
, pp. 5153
-
-
Kotsuki, H.1
Ushio, Y.2
Kadota, I.3
Ochi, M.4
|